carbon tetrabromide has been researched along with Cirrhosis, Liver in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dong, F; Song, D; Tian, H; Wu, H; Wu, W; Zeng, J; Zhang, L | 1 |
Calabro, SR; d'Avigdor, W; Lee, M; Locarnini, SA; Maczurek, AE; McCaughan, GW; McLennan, SV; Morgan, AJ; Mridha, A; Shackel, NA; Tu, T; Warner, FJ; Wen, VW; Yee, C | 1 |
2 other study(ies) available for carbon tetrabromide and Cirrhosis, Liver
Article | Year |
---|---|
Knockdown of TXNDC5 alleviates CCL4-induced hepatic fibrosis in mice by enhancing endoplasmic reticulum stress.
Topics: Animals; Collagen; Disease Models, Animal; Endoplasmic Reticulum Stress; Fibrosis; Hepatic Stellate Cells; Liver Cirrhosis; Mice; Transforming Growth Factor beta1 | 2023 |
Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesis.
Topics: Animals; Basigin; Cells, Cultured; Chemical and Drug Induced Liver Injury; Hepatocytes; Humans; Hydrocarbons, Brominated; Immunohistochemistry; Liver; Liver Cirrhosis; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Tissue Inhibitor of Metalloproteinases | 2014 |